Recent studies, utilizing similar animal models of asthma, using different EGFR tyrosine kinase inhibitors, such gefitnib and erlotinibin showed marked reductions in EGFR phosphorylation accompanied by dampening of several features of asthma, such cellular influx and airway remodeling5, 39. Here, EGFR is linked to asthma.